Has Andrew Locke, MD received payments from drug or device companies?

Yes. Drug and device makers reported $144,712 in general payments to Andrew Locke, MD across 265 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Andrew Locke, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Andrew Locke, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Andrew Locke, MD

Clinical Cardiac Electrophysiology · Boston, MANPI 1922445055

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $103,284 of the $144,711 with a category attached, or 71.4%. It is spread thinly across 13 manufacturers, the largest accounting for just 23.2%. 2025 is the largest year on record at $51,083, more than ten times the $1,194 reported in 2019.

$144,712in general payments, 2019–2025

Across 265 payments — averaging $546.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Biosense Webster, Inc.$34K
Abbott$30K
Edwards Lifesciences$24K
Medical Device Business Services, Inc.$21K
Boston Scientific$17K
Medtronic$11K
plus $9K from 7 others

$231,242in research payments, 2019–2025

Across 11 payments — averaging $21,022 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Haemonetics Corporation$231K

What the payments were for

Consulting fees$103,28471%
Speaking & faculty fees$1,2001%
Grants$25,49018%
Travel & lodging$3,5472%
Food & beverage$10,4977%
Education$6950%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Biosense Webster, Inc.	63	$33,617
Abbott	106	$29,707
Edwards Lifesciences	24	$23,790
Medical Device Business Services, Inc.	11	$21,230
Boston Scientific	18	$16,892
Medtronic(2 entities)	8	$10,905
Biotronik Inc.	28	$4,557
Circa Scientific, Inc.	1	$3,750
Impulse Dynamics (USA) Inc.	1	$140
Cordis US CORP.	2	$47
Kavo Dental Technologies LLC	1	$39
Siemens Medical Solutions USA, Inc.	1	$20
Cardiva Medical, Inc.	1	$17

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Carto 3$53,426
EMBLEM S ICD ELECTRODE DELIVERY SYSTEM$15,000
ENSITE$8,390
THORATEC HEARTMATE 3 LVAS IMPLANT KIT$5,250
ENSITE PRECISION$4,162
AGILIS$3,850
TACTICATH ABLATION CATHETER, SENSOR ENABLED$3,378
BioMonitor$1,733
Acticor$1,583
Rivacor$1,583
Solia$1,583
Edora$1,583
GENERAL - THERAPIES$1,047
Acticor 7 VR-T DX$675
HeartMate 3 Left Ventricular Dev$402
EnSite Precision Cardiac Mapping System$304
GALLANT$289
OPTIMIZER$280
QDOT MICRO Catheter$250
AMPLATZER AMULET$213

How this compares

$144,712 in reported general payments places this provider in the 85th percentile of 106 clinical cardiac electrophysiology providers in Massachusetts.

See all clinical cardiac electrophysiology providers in Massachusetts →

Medicare billing

Part B allowed, 2024

$197,808

Medicare patients

639

Services billed

1,655

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
EliquisApixaban	94	$76,317
XareltoRivaroxaban	11	$9,271
Metoprolol Succinate	64	$1,468
Amiodarone Hcl	42	$868
Diltiazem 24hr Er (Cd)Diltiazem Hcl	14	$340

Paid to pharmacies, not to this prescriber.

Other clinical cardiac electrophysiology in Boston

Elad AnterBoston$3.9M
Jagmeet SinghBoston$619K
Andre DavilaBoston$379K
Daniel KramerBoston$247K
Gregory MichaudBoston$244K
Laurence EpsteinBoston$172K
Leon PtaszekBoston$168K
Moussa MansourBoston$145K
Peter ZimetbaumBoston$144K
Timothy MaherBoston$123K

See the full list for Massachusetts →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →